132 related articles for article (PubMed ID: 2360759)
1. Hormone replacement therapy and the risk for first hip fracture. A prospective, population-based cohort study.
Naessén T; Persson I; Adami HO; Bergström R; Bergkvist L
Ann Intern Med; 1990 Jul; 113(2):95-103. PubMed ID: 2360759
[TBL] [Abstract][Full Text] [Related]
2. The risk of hip fractures in patients with primary hyperparathyroidism: a population-based cohort study with a follow-up of 19 years.
Larsson K; Ljunghall S; Krusemo UB; Naessén T; Lindh E; Persson I
J Intern Med; 1993 Dec; 234(6):585-93. PubMed ID: 8258750
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy and risk of hip fracture: population based case-control study. The Swedish Hip Fracture Study Group.
Michaëlsson K; Baron JA; Farahmand BY; Johnell O; Magnusson C; Persson PG; Persson I; Ljunghall S
BMJ; 1998 Jun; 316(7148):1858-63. PubMed ID: 9632404
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy and the risk of stroke. Follow-up of a population-based cohort in Sweden.
Falkeborn M; Persson I; Terént A; Adami HO; Lithell H; Bergström R
Arch Intern Med; 1993 May; 153(10):1201-9. PubMed ID: 8388207
[TBL] [Abstract][Full Text] [Related]
5. Postmenopausal hormone therapy and risk of cardiovascular disease and hip fracture in a cohort of Swedish women.
Grodstein F; Stampfer MJ; Falkeborn M; Naessen T; Persson I
Epidemiology; 1999 Sep; 10(5):476-80. PubMed ID: 10468418
[TBL] [Abstract][Full Text] [Related]
6. Use of low potency estrogens does not reduce the risk of hip fracture.
Michaëlsson K; Baron JA; Farahmand BY; Ljunghall S
Bone; 2002 Apr; 30(4):613-8. PubMed ID: 11934654
[TBL] [Abstract][Full Text] [Related]
7. Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study.
Kiel DP; Felson DT; Anderson JJ; Wilson PW; Moskowitz MA
N Engl J Med; 1987 Nov; 317(19):1169-74. PubMed ID: 3657888
[TBL] [Abstract][Full Text] [Related]
8. Time trends in incidence rates of first hip fracture in the Uppsala Health Care Region, Sweden, 1965-1983.
Naessén T; Parker R; Persson I; Zack M; Adami HO
Am J Epidemiol; 1989 Aug; 130(2):289-99. PubMed ID: 2487033
[TBL] [Abstract][Full Text] [Related]
9. Hip fractures in women with breast cancer.
Adami HO; Zack M; Kressner U; Persson I; Berglund A; Naessén T; Bergkvist L
Am J Epidemiol; 1990 Nov; 132(5):877-83. PubMed ID: 2239902
[TBL] [Abstract][Full Text] [Related]
10. Declining incidence trends for hip fractures have not been accompanied by improvements in lifetime risk or post-fracture survival--A nationwide study of the Swedish population 60 years and older.
Karampampa K; Ahlbom A; Michaëlsson K; Andersson T; Drefahl S; Modig K
Bone; 2015 Sep; 78():55-61. PubMed ID: 25933944
[TBL] [Abstract][Full Text] [Related]
11. Differences in risk factor patterns between cervical and trochanteric hip fractures. Swedish Hip Fracture Study Group.
Michaëlsson K; Weiderpass E; Farahmand BY; Baron JA; Persson PG; Zidén L; Zetterberg C; Ljunghall S
Osteoporos Int; 1999; 10(6):487-94. PubMed ID: 10663350
[TBL] [Abstract][Full Text] [Related]
12. Smoking eliminates the protective effect of oral estrogens on the risk for hip fracture among women.
Kiel DP; Baron JA; Anderson JJ; Hannan MT; Felson DT
Ann Intern Med; 1992 May; 116(9):716-21. PubMed ID: 1558342
[TBL] [Abstract][Full Text] [Related]
13. The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement.
Falkeborn M; Persson I; Adami HO; Bergström R; Eaker E; Lithell H; Mohsen R; Naessén T
Br J Obstet Gynaecol; 1992 Oct; 99(10):821-8. PubMed ID: 1419993
[TBL] [Abstract][Full Text] [Related]
14. Lifestyle factors and site-specific risk of hip fracture in community dwelling older women--a 13-year prospective population-based cohort study.
Määttä M; Terho E; Jokinen H; Pulkkinen P; Korpelainen J; Heikkinen J; Keinänen-Kiukaanniemi S; Jämsä T; Korpelainen R
BMC Musculoskelet Disord; 2012 Sep; 13():173. PubMed ID: 22978821
[TBL] [Abstract][Full Text] [Related]
15. Risk for fracture in women with low serum levels of thyroid-stimulating hormone.
Bauer DC; Ettinger B; Nevitt MC; Stone KL;
Ann Intern Med; 2001 Apr; 134(7):561-8. PubMed ID: 12803168
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for hip fractures in a middle-aged population: a study of 33,000 men and women.
Holmberg AH; Johnell O; Nilsson PM; Nilsson JA; Berglund G; Akesson K
Osteoporos Int; 2005 Dec; 16(12):2185-94. PubMed ID: 16177836
[TBL] [Abstract][Full Text] [Related]
17. Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study.
Persson I; Adami HO; Bergkvist L; Lindgren A; Pettersson B; Hoover R; Schairer C
BMJ; 1989 Jan; 298(6667):147-51. PubMed ID: 2538173
[TBL] [Abstract][Full Text] [Related]
18. Variation in the efficacy of hormone replacement therapy in the prevention of hip fracture. Swedish Hip Fracture Study Group.
Michaëlsson K; Baron JA; Johnell O; Persson I; Ljunghall S
Osteoporos Int; 1998; 8(6):540-6. PubMed ID: 10326058
[TBL] [Abstract][Full Text] [Related]
19. Rapid loss of hip fracture protection after estrogen cessation: evidence from the National Osteoporosis Risk Assessment.
Yates J; Barrett-Connor E; Barlas S; Chen YT; Miller PD; Siris ES
Obstet Gynecol; 2004 Mar; 103(3):440-6. PubMed ID: 14990403
[TBL] [Abstract][Full Text] [Related]
20. Reduced risk of hip fracture in women with endometrial cancer.
Persson I; Naessén T; Adami HO; Bergström R; Lagrelius A; Möllerström G; Pettersson B; von Hamos K
Int J Epidemiol; 1992 Aug; 21(4):636-42. PubMed ID: 1521965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
